Data as of November 13, 2026

Bonjesta ER 20-20 mg Tablet

DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

Brand: BONJESTA

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$508.99/ fill$11.11 / EA
VA Big4
$392.86/ fill$8.58 / EA
Medicaid FFS
$565.55/ fill
Medicaid MCO
$493.86/ fill

Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/sdud

What's in the reimbursement

Ingredient cost (45.8 units/fill)$508.99
Dispensing fee & other (state-fixed, not margin)$56.56
Total reimbursed per fill$565.55

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 5 fee-for-service states, 10 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology